CFO exercised or converted 12K TECH derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Nov 3, 2025
- Reporting period
- Not applicable
- Filed with the SEC
- Nov 5, 2025
CFOOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0000914190-25-000030
Filed / recordedNov 5, 2025, 9:46 PM UTCAdded to OQROOct 2, 2026, 12:27 PM UTC Data qualityVerified: identifiers matched exactly Reporting personJames Hippel SecurityRestricted Stock Units TableDerivative (Table II) Transaction dateNov 3, 2025 Acquired / disposedDisposed (D) Footnotes from the filing
- Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
- 11,545 restricted stock units vest on each of 11/1/2025 and 11/1/2026; and 11,544 restricted stock units vest on 11/1/2027.
Around the same time
The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Routine share withholding; mechanical by default.
Derivative exercise or conversion — not an open-market buy.